ArticleJournal of thoracic disease2023

Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review.

Kanghao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.